UCB (UCBJF)
(Delayed Data from OTC)
$179.05 USD
0.00 (0.00%)
Updated Sep 16, 2024 12:46 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for UCB SA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5,684 | 5,813 | 6,835 | 6,108 | 5,503 |
Cost Of Goods | 1,847 | 1,764 | 1,701 | 1,557 | 1,420 |
Gross Profit | 3,837 | 4,049 | 5,133 | 4,551 | 4,082 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,126 | 3,338 | 3,574 | 3,302 | 2,830 |
Income After Depreciation & Amortization | 711 | 711 | 1,559 | 1,249 | 1,252 |
Non-Operating Income | -6 | -55 | 54 | -121 | -37 |
Interest Expense | 227 | 118 | 163 | 122 | 140 |
Pretax Income | 477 | 538 | 1,450 | 1,005 | 1,075 |
Income Taxes | 106 | 96 | 201 | 136 | 164 |
Minority Interest | 0 | 0 | 0 | 33 | 28 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 371 | 443 | 1,249 | 869 | 912 |
Extras & Discontinued Operations | 0 | -2 | 4 | 0 | 2 |
Net Income (GAAP) | 371 | 440 | 1,252 | 836 | 887 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 711 | 1,332 | 1,559 | 1,249 | 1,252 |
Depreciation & Amortization (Cash Flow) | 0 | 621 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 711 | 711 | 1,559 | 1,249 | 1,252 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 194.89 | 190.00 | 189.00 | 189.00 | 187.00 |
Diluted EPS Before Non-Recurring Items | 4.54 | 4.61 | 7.67 | 6.12 | 5.82 |
Diluted Net EPS (GAAP) | 1.90 | 2.25 | 6.45 | 4.31 | 4.74 |
Fiscal Year end for UCB SA falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |